These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2861620)

  • 1. Effects of carbamazepine on cerebrospinal fluid somatostatin.
    Rubinow DR; Post RM; Gold PW; Ballenger JC; Reichlin S
    Psychopharmacology (Berl); 1985; 85(2):210-3. PubMed ID: 2861620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF somatostatin in affective illness and normal volunteers.
    Rubinow DR; Gold PW; Post RM; Ballenger JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):393-400. PubMed ID: 2866561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR
    Biol Psychiatry; 1986 Apr; 21(4):341-65. PubMed ID: 2869790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness.
    Post RM; Uhde TW; Rubinow DR; Ballenger JC; Gold PW
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):263-71. PubMed ID: 6137029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cerebrospinal fluid somatostatin and peripheral thyroid hormones with carbamazepine treatment.
    Joffe RT; Rubinow DR; Post RM; Uhde TW
    Neuropsychobiology; 1985; 14(3):115-7. PubMed ID: 2870442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid.
    Post RM; Ballenger JC; Hare TA; Bunney WE
    Neurology; 1980 Sep; 30(9):1008-11. PubMed ID: 7191529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF somatostatin in affective illness.
    Rubinow DR; Gold PW; Post RM; Ballenger JC; Cowdry R; Bollinger J; Reichlin S
    Arch Gen Psychiatry; 1983 Apr; 40(4):409-12. PubMed ID: 6132592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone.
    Joffe RT; Gold PW; Uhde TW; Post RM
    Psychiatry Res; 1984 Jun; 12(2):161-6. PubMed ID: 6433372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder.
    Black PM; Ballantine HT; Carr DB; Beal MF; Martin JB
    Biol Psychiatry; 1986 Sep; 21(11):1077-81. PubMed ID: 2874844
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
    Marangell LB; George MS; Bissette G; Pazzaglia P; Huggins T; Post RM
    Arch Gen Psychiatry; 1994 Aug; 51(8):625-8. PubMed ID: 8042911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
    Post RM
    Psychol Med; 1982 Nov; 12(4):701-4. PubMed ID: 6130553
    [No Abstract]   [Full Text] [Related]  

  • 13. Time course of clinical effects of carbamazepine: implications for mechanisms of action.
    Post RM
    J Clin Psychiatry; 1988 Apr; 49 Suppl():35-48. PubMed ID: 3280560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of carbamazepine in affective illness.
    Post RM; Uhde TW; Ballenger JC
    Adv Biochem Psychopharmacol; 1984; 39():421-37. PubMed ID: 6380232
    [No Abstract]   [Full Text] [Related]  

  • 15. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.
    George MS; Guidotti A; Rubinow D; Pan B; Mikalauskas K; Post RM
    Biol Psychiatry; 1994 May; 35(10):775-80. PubMed ID: 8043707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response.
    Post RM; Pickar D; Naber D; Ballenger JC; Uhde TW; Bunney WE
    Psychiatry Res; 1981 Aug; 5(1):59-66. PubMed ID: 6269141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness. An overview.
    Vecsei L; Widerlöv E
    Acta Psychiatr Scand; 1988 Dec; 78(6):657-67. PubMed ID: 2906214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with carbamazepine affects CSF somatostatin immunoreactivity in epileptic patients.
    Steardo L; Testa N; Perez J; Attanasio A; Sorge F; Steardo MR; Biondi A
    Acta Neurol (Napoli); 1992; 14(4-6):320-5. PubMed ID: 1363457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.